Why it was included in the FDA ban The agency cited a lack of human trials and the risk for immune reactions and peptide impurities with injectable Thymosin Beta 4
Bnh tiu ng Type 2: Gip lm tng tnh nhy cm vi insulin, t h tr kim sot ng huyt tt hn
Sundelin et al., 2017
Ingredients: Water, Triethylhexanoin, Hydrogenated Poly(C6-14 Olefin), Butylene Glycol, 1,2-Hexanediol, Methyl Propanediol, Niacinamide, Phenyl Trimethicone, Diethoxyethyl Succinate, Polyglyceryl-10 Myristate, Fragrance, Hippophae Rhamnoides Oil, Ethylhexyl Glycerin, Allantoin, Hydrogenated Lecithin, Hibiscus Esculentus Fruit Extract, Corchorus Olitorius Leaf Extract, Carum Petroselinum (Parsley) Extract, Glutathione, Sodium Gluconate, Adenosine, Cellulose Gum, Hexylcinnamal, Gluconolactone, Melia Azadirachta Leaf Extract, Linalool, Melia Azadirachta Flower Extract, Lavandula Angustifolia (Lavender) Flower Water, Hyacinthus Orientalis (Hyacinth) Extract, Centaurea Cyanus Flow Er Extract, Chamomilla Recutita (Matricaria) Flower/Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Borago Officinalis Extract, Salvia Sclarea (Clary) Extract, Limonene, Alpha- Arbutin, Ocimum Sanctum Leaf Extract, Corallina Officinalis Extract, Thio Citric Acid, Biotin, Biotinoyl Tripeptide-1, Acetyl Hexapeptide-8, Tripeptide-1, Tri Peptide-3, Myristoyl Pentapeptide-17, Hexapeptide-9
